These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Beta-cryptoxanthin stimulates apoptotic cell death and suppresses cell function in osteoclastic cells: change in their related gene expression. Uchiyama S, Yamaguchi M. J Cell Biochem; 2006 Aug 01; 98(5):1185-95. PubMed ID: 16514646 [Abstract] [Full Text] [Related]
3. Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte/macrophage lineage precursor cells. Yang CR, Wang JH, Hsieh SL, Wang SM, Hsu TL, Lin WW. Cell Death Differ; 2004 Jul 01; 11 Suppl 1():S97-107. PubMed ID: 15002040 [Abstract] [Full Text] [Related]
8. Autocrine and paracrine nitric oxide regulate attachment of human osteoclasts. Yaroslavskiy BB, Li Y, Ferguson DJ, Kalla SE, Oakley JI, Blair HC. J Cell Biochem; 2004 Apr 01; 91(5):962-72. PubMed ID: 15034931 [Abstract] [Full Text] [Related]
9. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption. Michael H, Härkönen PL, Väänänen HK, Hentunen TA. J Bone Miner Res; 2005 Dec 01; 20(12):2224-32. PubMed ID: 16294275 [Abstract] [Full Text] [Related]
10. Flavonoid quercetin decreases osteoclastic differentiation induced by RANKL via a mechanism involving NF kappa B and AP-1. Wattel A, Kamel S, Prouillet C, Petit JP, Lorget F, Offord E, Brazier M. J Cell Biochem; 2004 May 15; 92(2):285-95. PubMed ID: 15108355 [Abstract] [Full Text] [Related]
11. Cloning and characterization of osteoclast precursors from the RAW264.7 cell line. Cuetara BL, Crotti TN, O'Donoghue AJ, McHugh KP. In Vitro Cell Dev Biol Anim; 2006 May 15; 42(7):182-8. PubMed ID: 16948499 [Abstract] [Full Text] [Related]
13. Genistein and zinc synergistically stimulate apoptotic cell death and suppress RANKL signaling-related gene expression in osteoclastic cells. Uchiyama S, Yamaguchi M. J Cell Biochem; 2007 Jun 01; 101(3):529-42. PubMed ID: 17295206 [Abstract] [Full Text] [Related]
14. Modulation of the effects of osteoprotegerin (OPG) ligand in a human leukemic cell line by OPG and calcitonin. Mancini L, Moradi-Bidhendi N, Brandi ML, Perretti M, MacIntyre I. Biochem Biophys Res Commun; 2000 Dec 20; 279(2):391-7. PubMed ID: 11118297 [Abstract] [Full Text] [Related]
15. Effects of the phytoestrogen coumestrol on RANK-ligand-induced differentiation of osteoclasts. Kanno S, Hirano S, Kayama F. Toxicology; 2004 Oct 15; 203(1-3):211-20. PubMed ID: 15363596 [Abstract] [Full Text] [Related]
16. Interleukin-7 is a direct inhibitor of in vitro osteoclastogenesis. Lee SK, Kalinowski JF, Jastrzebski SL, Puddington L, Lorenzo JA. Endocrinology; 2003 Aug 15; 144(8):3524-31. PubMed ID: 12865334 [Abstract] [Full Text] [Related]
17. Interferon-gamma directly inhibits TRANCE-induced osteoclastogenesis. Fox SW, Chambers TJ. Biochem Biophys Res Commun; 2000 Oct 05; 276(3):868-72. PubMed ID: 11027561 [Abstract] [Full Text] [Related]
18. In vitro differentiation of CD14 cells from osteopetrotic subjects: contrasting phenotypes with TCIRG1, CLCN7, and attachment defects. Blair HC, Borysenko CW, Villa A, Schlesinger PH, Kalla SE, Yaroslavskiy BB, Garćia-Palacios V, Oakley JI, Orchard PJ. J Bone Miner Res; 2004 Aug 05; 19(8):1329-38. PubMed ID: 15231021 [Abstract] [Full Text] [Related]
19. Interleukin 4 increases type 5 acid phosphatase mRNA expression in murine bone marrow macrophages. Lacey DL, Erdmann JM, Tan HL. J Cell Biochem; 1994 Mar 05; 54(3):365-71. PubMed ID: 8200916 [Abstract] [Full Text] [Related]
20. Peripheral blood mononuclear phagocytes from patients with chronic periodontitis are primed for osteoclast formation. Herrera BS, Bastos AS, Coimbra LS, Teixeira SA, Rossa C, Van Dyke TE, Muscara MN, Spolidorio LC. J Periodontol; 2014 Apr 05; 85(4):e72-81. PubMed ID: 24059638 [Abstract] [Full Text] [Related] Page: [Next] [New Search]